Table 3.

Clinical and neurophysiological characteristics in the context of treatment: Values reflect mean and standard deviations are in parentheses

Measures	CBT (n = 57)*	ST (n = 51)*
Composite Score
Baseline (T1)	.88 (.24)	.88 (.24)
Week 2 (T2)	.78 (.26)	.84 (.27)
Week 4 (T3)	.70 (.30)	.72 (.26)
Week 6 (T4)	.63 (.29)	.72 (.29)
Week 8 (T5)	.61 (.32)	.67 (.30)
Week 10 (T6)	.52 (.26)	.61 (.33)
Week 12 (T7)	.48 (.30)	.60 (.32)
IDAS-II Suicidality Subscale
Baseline	7.86 (2.57)	7.72 (2.53)
Week 6	6.98 (2.26)	6.83 (1.66)
Week 12	6.54 (1.32)	7.12 (2.10)
TEPS-A
Baseline	4.04 (.76)	4.14 (.80)
Week 12	4.40 (.64)	4.31 (.78)
TEPS-C
Baseline	4.42 (.75)	4.50 (.74)
Week 12	4.79 (.79)	4.78 (.70)
ΔRewP at FCz (gain-loss)
Baseline	3.47 (4.49)	4.30 (4.80)
Week 6	3.64 (3.69)	2.56 (4.18)
Week 12	3.17 (4.08)	2.60 (4.36)

Note.

^*Reflects the number of participants randomly assigned to treatment arm; CBT = Cognitive Behavioral Therapy; ST = Supportive Therapy; Composite score = Liebowitz Social Anxiety Scale and Hamilton Depression Rating Scale using the proportion of maximum scaling; T = Time; IDAS-II = Inventory of Depression and Anxiety Symptoms – Second Version; TEPS-A = Temporal Experience of Pleasure Scale, anticipatory pleasure score; TEPS-C = Temporal Experience of Pleasure Scale, consummatory pleasure score; FCz = frontocentral event-related potential component based on difference score